Ten Washington state health organizations recently received grants of up to $15,000 from Fred Hutch Cancer Center’s Community ...

In 2024, Obliteride raised more than $9 million for research at Fred Hutch, contributing to more than $58 million raised since 2013. These funds have fueled urgently needed advances in cancer ...

At first glance, art and science might seem like opposite worlds — one driven by imagination and emotion, the other by data ...

Dr. Folashade Otegbeye, facility director of the Therapeutic Products Program at Fred Hutch, works to rapidly translate what ...

Patient provider profile for Dr. Michael Schweizer, medical oncologist at Fred Hutchinson Cancer Center.

Fred Hutch's mission is the elimination of cancer and related diseases as causes of human suffering and death through prevention and curative treatments accessible to all patients.

A study from Fred Hutch Cancer Center finds that some cancer patients' antibodies can boost their response to immunotherapy treatment.

A Fred Hutch Cancer Center outpatient complex serving more than 60,000 adult patients per year will be renamed the Sloan Clinic in recognition of Stuart and Molly Sloan, who have increased their total ...

The Pacific Northwest Prostate Cancer Specialized Program of Research Excellence (SPORE), one of eight Prostate Cancer SPOREs in the nation, represents a coordinated effort between Fred Hutch and ...

The Pacific Northwest (PNW) Prostate Cancer SPORE aims to focus on finding molecular and other factors associated with the risk of prostate cancer recurrence and progression as well as its response – ...